Skip to content
The Policy VaultThe Policy Vault

Gleevec (imatinib tablets) — Cigna

Chronic Graft-Versus-Host Disease

Initial criteria

  • Patient has tried at least one conventional systemic treatment for graft-versus-host disease

Approval duration

1 year